Prediction of obstetrical risk using maternal serum markers and clinical risk factors.

Metcalfe, Amy; Langlois, Sylvie; Macfarlane, Julie; Vallance, Hilary; Joseph, K S

Metcalfe, Amy; Langlois, Sylvie; Macfarlane, Julie; Vallance, Hilary; Joseph, K S.

Affiliation

Metcalfe A; Department of Obstetrics and Gynecology, University of British Columbia and the Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, Canada.

Prenat Diagn ; 34(2): 172-9, 2014 Feb.

Article in En | MEDLINE | ID: mdl-24226970

Subject(s)

Biomarkers/metabolism; HELLP Syndrome/metabolism; Pre-Eclampsia/metabolism; Premature Birth/metabolism; Reproductive History; Risk Assessment/methods; Adult; Area Under Curve; Chorionic Gonadotropin, beta Subunit, Human/metabolism; Estriol/metabolism; Female; HELLP Syndrome/epidemiology; Humans; Inhibins/metabolism; Logistic Models; Parity; Pre-Eclampsia/epidemiology; Pregnancy; Pregnancy-Associated Plasma Protein-A/metabolism; Premature Birth/epidemiology; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Smoking/epidemiology; Stillbirth/epidemiology; alpha-Fetoproteins/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pre-Eclampsia / Biomarkers / HELLP Syndrome / Reproductive History / Risk Assessment / Premature Birth Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Prenat Diagn Year: 2014 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google